Clinical trial
Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958
NCT00311714 · Biota Scientific Management Pty Ltd, Industry · Completed
Key facts
| NCT number | NCT00311714 |
|---|---|
| Title | Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958 |
| Official title | CS-8958 - A Phase I, Double-Blind, Placebo-Controlled, Ascending Single Inhaled Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects |
| Lead sponsor | Biota Scientific Management Pty Ltd, Industry |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug, Other |
| Interventions | CS-8958 formulated as dry powder, Placebo |
| Enrollment | 40 |
| Start date | Apr 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 6, 2006 |
| Last update posted | May 30, 2018 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: